PT1545553E - Utilização de alquilfosfocolinas em combinação com medicamentos antitumorais - Google Patents

Utilização de alquilfosfocolinas em combinação com medicamentos antitumorais Download PDF

Info

Publication number
PT1545553E
PT1545553E PT03766336T PT03766336T PT1545553E PT 1545553 E PT1545553 E PT 1545553E PT 03766336 T PT03766336 T PT 03766336T PT 03766336 T PT03766336 T PT 03766336T PT 1545553 E PT1545553 E PT 1545553E
Authority
PT
Portugal
Prior art keywords
combination
antitumor medicaments
alkyl phosphocholines
phosphocholines
alkyl
Prior art date
Application number
PT03766336T
Other languages
English (en)
Portuguese (pt)
Inventor
Eckhard Guenther
Juergen Engel
Herbert Sindermann
Original Assignee
Aeterna Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aeterna Zentaris Gmbh filed Critical Aeterna Zentaris Gmbh
Publication of PT1545553E publication Critical patent/PT1545553E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT03766336T 2002-07-30 2003-07-29 Utilização de alquilfosfocolinas em combinação com medicamentos antitumorais PT1545553E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39961502P 2002-07-30 2002-07-30

Publications (1)

Publication Number Publication Date
PT1545553E true PT1545553E (pt) 2011-09-12

Family

ID=31495746

Family Applications (1)

Application Number Title Priority Date Filing Date
PT03766336T PT1545553E (pt) 2002-07-30 2003-07-29 Utilização de alquilfosfocolinas em combinação com medicamentos antitumorais

Country Status (26)

Country Link
US (3) US8389497B2 (OSRAM)
EP (2) EP2301551A1 (OSRAM)
JP (1) JP2005535688A (OSRAM)
KR (3) KR20110102485A (OSRAM)
CN (1) CN1302780C (OSRAM)
AR (1) AR040717A1 (OSRAM)
AT (1) ATE516036T1 (OSRAM)
AU (2) AU2003253350B2 (OSRAM)
BR (1) BR0313048A (OSRAM)
CA (1) CA2493023C (OSRAM)
CY (1) CY1111902T1 (OSRAM)
DK (1) DK1545553T3 (OSRAM)
ES (1) ES2369535T3 (OSRAM)
HR (1) HRP20050184B1 (OSRAM)
IL (1) IL166329A (OSRAM)
MX (1) MXPA05001203A (OSRAM)
NO (1) NO335196B1 (OSRAM)
NZ (1) NZ538428A (OSRAM)
PL (1) PL375493A1 (OSRAM)
PT (1) PT1545553E (OSRAM)
RU (1) RU2005105693A (OSRAM)
SI (1) SI1545553T1 (OSRAM)
TW (1) TWI332007B (OSRAM)
UA (1) UA82322C2 (OSRAM)
WO (1) WO2004012744A1 (OSRAM)
ZA (1) ZA200500453B (OSRAM)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8383605B2 (en) 2002-07-30 2013-02-26 Aeterna Zentaris Gmbh Use of alkylphosphocholines in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals
AR040717A1 (es) 2002-07-30 2005-04-20 Zentaris Ag Uso de alquilfosfocolinas en cominacion con medicamentos antitumorales para el tratamiento de oncosis maligna y benigna en seres humanos y animales
DE10324911B4 (de) 2003-05-30 2005-08-18 Siemens Ag Röntgenvorrichtung mit partiellem digitalem Detektor und Verfahren zum Betrieb einer solchen
WO2006081452A2 (en) * 2005-01-28 2006-08-03 Robert Birch Co-administration of perifosine with chemotherapeutics
EP1800684A1 (en) * 2005-12-20 2007-06-27 Zentaris GmbH Novel alkyl phospholipid derivatives and uses thereof
UA99434C2 (ru) * 2005-12-19 2012-08-27 Аетерна Центаріс Гмбх Применение производных алкилфосфолипидов со сниженной цитотоксичностью
PL1962862T3 (pl) * 2005-12-19 2014-01-31 Aeterna Zentaris Gmbh Pochodne alkilofosfolipidów o ograniczonej cytotoksyczności i ich zastosowania
US8703179B2 (en) 2006-05-11 2014-04-22 Kimberly-Clark Worldwide, Inc. Mucosal formulation
AU2008282338B2 (en) * 2007-07-30 2015-02-12 Ardea Biosciences, Inc. Derivatives of N-(arylamino) sulfonamides including polymorphs as inhibitors of MEK as well as compositions, methods of use and methods for preparing the same
US20120128732A1 (en) * 2008-12-11 2012-05-24 Vuong Trieu Combinations and modes of administration of therapeutic agents and combination therapy
WO2011123691A1 (en) 2010-03-31 2011-10-06 Keryx Biopharmaceuticals, Inc. Perifosine and capecitabine as a combined treatment for cancer

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4219972A1 (de) * 1991-07-04 1993-01-07 Asta Medica Ag Arzneimittel mit antineoplastischer wirkung enthaltend als wirkstoff octadecyl-(2-(n-methylpiperidino)-ethyl)-phosphat und verfahren zu dessen herstellung
US5942639A (en) * 1991-07-04 1999-08-24 Asta Medica Aktiengesellschaft Process for the preparation of alkylphosphocholines and the production thereof in pure form
US6172050B1 (en) * 1992-07-11 2001-01-09 Asta Medica Aktiengesellschaft Phospholipid derivatives
JP3079993B2 (ja) * 1996-03-27 2000-08-21 日本電気株式会社 真空マイクロデバイスおよびその製造方法
DE19650778C2 (de) * 1996-12-06 2001-01-04 Asta Medica Ag Verwendung von Dopaminrezeptor-Antagonisten in der palliativen Tumortherapie
CN100413492C (zh) * 1998-01-22 2008-08-27 赞塔里斯有限公司 口服给药治疗利什曼病的含有米替福星的固体药物组合物
DE19959689A1 (de) * 1998-12-04 2000-06-08 Max Delbrueck Centrum Mittel zur Tumortherapie
DE69924146D1 (de) * 1998-12-21 2005-04-14 Inkeysa Sa Etherlysophospholipide zur behandlung von chronischen entzündlichen erkrankungen
EP2762140B1 (en) * 2001-02-19 2017-03-22 Novartis AG Treatment of solid brain tumours with a rapamycin derivative
KR20040018341A (ko) * 2001-03-23 2004-03-03 샤이어 바이오켐 인코포레이티드 암치료용 약제 조성물
WO2003005522A1 (es) 2001-07-04 2003-01-16 Acuna Arturo Tapones para sellado de ductos para redes electricas, telefonicas y de fibra optica.
PL371179A1 (en) * 2002-01-02 2005-06-13 Pharmacia Italia S.P.A. Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors
AR040717A1 (es) 2002-07-30 2005-04-20 Zentaris Ag Uso de alquilfosfocolinas en cominacion con medicamentos antitumorales para el tratamiento de oncosis maligna y benigna en seres humanos y animales
WO2005000318A2 (en) * 2003-06-23 2005-01-06 Neopharm, Inc. Method of inducing apoptosis and inhibiting cardiolipin synthesis
WO2006081452A2 (en) 2005-01-28 2006-08-03 Robert Birch Co-administration of perifosine with chemotherapeutics
UA99434C2 (ru) * 2005-12-19 2012-08-27 Аетерна Центаріс Гмбх Применение производных алкилфосфолипидов со сниженной цитотоксичностью
WO2011123691A1 (en) 2010-03-31 2011-10-06 Keryx Biopharmaceuticals, Inc. Perifosine and capecitabine as a combined treatment for cancer

Also Published As

Publication number Publication date
US20040097470A1 (en) 2004-05-20
HRP20050184A2 (en) 2005-04-30
SI1545553T1 (sl) 2011-09-30
RU2005105693A (ru) 2005-07-10
ES2369535T3 (es) 2011-12-01
EP2301551A1 (de) 2011-03-30
US8551977B2 (en) 2013-10-08
HK1080751A1 (en) 2006-05-04
KR20110102485A (ko) 2011-09-16
ZA200500453B (en) 2005-08-31
AR040717A1 (es) 2005-04-20
KR20130016413A (ko) 2013-02-14
HRP20050184B1 (hr) 2014-04-11
PL375493A1 (en) 2005-11-28
IL166329A0 (en) 2006-01-15
EP1545553B1 (de) 2011-07-13
IL166329A (en) 2012-08-30
KR20050026028A (ko) 2005-03-14
US20100189784A1 (en) 2010-07-29
EP1545553A1 (de) 2005-06-29
BR0313048A (pt) 2005-06-14
CN1671397A (zh) 2005-09-21
JP2005535688A (ja) 2005-11-24
CA2493023C (en) 2012-01-31
ATE516036T1 (de) 2011-07-15
US8507710B2 (en) 2013-08-13
NO335196B1 (no) 2014-10-20
MXPA05001203A (es) 2005-06-08
AU2003253350B2 (en) 2008-06-26
TWI332007B (en) 2010-10-21
CY1111902T1 (el) 2015-11-04
AU2003253350A1 (en) 2004-02-23
NO20051040L (no) 2005-02-25
US8389497B2 (en) 2013-03-05
WO2004012744A1 (de) 2004-02-12
CA2493023A1 (en) 2004-02-12
NZ538428A (en) 2006-09-29
UA82322C2 (uk) 2008-04-10
KR101066804B1 (ko) 2011-09-22
AU2008203060A1 (en) 2008-07-31
AU2008203060B2 (en) 2011-04-21
US20100190738A1 (en) 2010-07-29
CN1302780C (zh) 2007-03-07
TW200404073A (en) 2004-03-16
DK1545553T3 (da) 2011-09-12

Similar Documents

Publication Publication Date Title
IL154761A0 (en) Improved paclitaxel-based antitumor formulation
IL187528A0 (en) Use of pyrimidine compounds in the manufacture of medicaments
IL150240A (en) Infant formula supplemented with phospholipids
IL166156A0 (en) Boroproline compound combination therapy
IL169112A0 (en) Phosphonooxy quinazoline derivatives and their pharmaceuitical use
GB0321911D0 (en) Improvements in or relating to medical devices
GB0324761D0 (en) Use of compounds in therapy
IL164193A0 (en) Combined use of antitumor indolopyrrolocarbazole derivative and other antitumor agent
HRP20050631A2 (en) Aryl alkyl carbamate derivatives production and use thereof in therapy
AU2003287666A8 (en) Systemic delivery of antiviral agents
IL166329A0 (en) Use of alkyl phosphocholines in combination with antitumor medicaments
GB2410209B (en) Improvements in or relating to devices
AU2003242405A1 (en) Compounds and preparaitons having antiviral effect
AU2003264796A8 (en) Three-dimensional display
IL169692A0 (en) Acylated aminopropanediols and analogues and therapeutic uses thereof
TWI339582B (en) Use of alkylphosphocholines in the preventive application of protozoal diseases
EP1507542A4 (en) ANTICANCER PREPARATION
GB2400225B (en) Improvements in and relating to display devices
GB0215773D0 (en) Compunds and their therapeutic use
GB0230292D0 (en) Anti-cancer agents
GB0305969D0 (en) Improvements in the formulation of medicaments
GB0313836D0 (en) Improvements in and relating to the dispensing of medicaments
GB2395832B (en) Improvements in and relating to display devices
GB0204909D0 (en) Improvements in or relating to antimalarial agents
GB0312845D0 (en) Use of componds in medicine